Pancreatic Cell Line Mutational Status Overview

Jun 21, 2025

10 likes | 96 Views

Explore the mutational status of pancreatic cell lines used in research to understand genetic variations for medical advancements.

Share Presentation

Embed Code

Link

pancreatic
cell lines
mutational status
genetic variations
research
medical advancements

fahim

Download Presentation

Pancreatic Cell Line Mutational Status Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Table S1. Mutational status of pancreatic cell lines used.

Mutational analysis of 35 bladder cancer cell lines using RNA-seq

Mutational analysis of 35 bladder cancer cell lines using RNA-seq. RNA-seq. Cell lines. Genes. Frequently mutated networks in bladder cancer cell lines. Mutations in CBP/p300 network. Fusion. Missense . Nonsense. Mutations in chromatin remodelling genes. Fusion. Missense . Nonsense.

226 views • 10 slides

Table S1

Table S1. Table S1. The primer list used in the present study.

133 views • 1 slides

Supplemental Table S1

Supplemental Table S1. For Site Directed Mutagenesis and cloning of constructs P9GF: 5’ GAC GCT ACT TCA CTA TAG ATA GGA AGT TCA TTT C 3’ P9GR: 5’ GAA ATG AAC TTC CTA TCT ATA GTG AAG TAG CGT C 3’ LAP9GF: 5’ CCC GGA TCC ATC ACT ATA GAT AGG AAG TTC ATT TCA TTT G 3’

272 views • 3 slides

Table S1. Primers used for semiquantitative RT-PCR

Table S1. Primers used for semiquantitative RT-PCR. 4. 4. 10. 10. 3. 3. 10. 10. 93.4. 96.6. 2. 2. 10. 10. 1. 1. 10. 10. 0. 0. 10. 10. 0. 1. 2. 3. 4. 0. 1. 2. 3. 4. 10. 10. 10. 10. 10. 10. 10. 10. 10. 10.

115 views • 3 slides

(Table S1)

(Table S1). B. A. B. E. F. anterior. C. E. posterior. F. (Figure S1). ON. lCa. lCa. m. lo. SOG. PB. C. D. E. D. lCa. CC. Pe. CC. 1.E+02. 1.E+01. 1.E+00. 1.E-01. Relative Kakugo content. 1.E-02. 1.E-03. 1.E-04. days. 0. 1. 4. 6. 9. 14. (4). (3). (3).

190 views • 7 slides

Supplementary Table S1

Relationship between the miRNA-21 in plasma and primary ESCC tissues. Supplementary Table S1. Relationship between the miRNA-375 in plasma and primary ESCC tissues. Supplementary Table S2. 1.0. 1.0. 0.8. 0.8. 0.6. 0.6. 0.4. 0.4. 0.2. 0.2. miR-21 AUC=0.618. miR-375 AUC=0.807. 0. 0.

104 views • 3 slides

Supplemental Table S1

Supplemental Table S1. Table S1. Quantitative real-time RT-PCR primer sequences for genes used in the publication. All sequences are listed in the 5’ – 3’ direction. Supplemental Fig. S1. Induced by E2 and IGF-I. 3hr. 24hr. Repressed by E2 and IGF-I. 3hr. 24hr.

149 views • 4 slides

Table S1. Organisms used for lytA specificity studies

Table S1. Organisms used for lytA specificity studies. lytA 173bp PCR product. Organism. Strain. Streptococcus pneumoniae. ATCC 49619. positive. Streptococcus pneumoniae. ATCC 6303. positive. Streptococcus pneumoniae. positive. ATCC 6305. Streptococcus pneumoniae. positive.

186 views • 1 slides

TABLE S1

TABLE S1.

100 views • 1 slides

Table. S1

Table. S1.

125 views • 1 slides

Table S1

0.023. 0.023. 0.23. 0.23. 2.3. 2.3. 23 c. 23. 5.5. 24.9. 65.07. 4.7. 44.9. 171.3. 1.2. 1.5. 2.3. 1.1. 1.1. 2.1. Table S1. 5-Me-Tetrahydrofolate (5-MeTHF). Folic acid (FA). Tetrahydrofolate (THF). IC 50 s (nM) in physiological folate (FA 0.023 µM).

145 views • 1 slides

Supplementary Table S1.

Supplementary Table S1. Primer sequences used for PCR amplification of DDAH1, DDAH2 and tubulin message. Supplementary Figures. s1A. s1B. s1C. s1D.

239 views • 6 slides

Supplementary Table S1

Supplementary Table S1.

101 views • 1 slides

Table S1

Table S1.

124 views • 1 slides

Supplementary Table S1 . Summary of cell lines used.

187 views • 2 slides

Table S1: Parameters used for collection of the switchgrass internodes.

Table S1: Parameters used for collection of the switchgrass internodes. Values are means ± SE (n=30).

63 views • 1 slides

Supplementary Table S1

Supplementary Table S1. Clinicopathological features of 3 GC patients analysed on miRNA microarray.

126 views • 1 slides

Supplemental Table S1

Supplemental Table S1. Complete list of LC-MS myc interating protiens in the MCF7 cells, proteins highlighted in red are those differentially expressed from the LCC1 and LCC1 EGF treated cells. Supplemental Table S2.

156 views • 4 slides

Table S1 . (Continued)

Table S1 . List of primers used for the amplification of DNA fragments that were used as probes for Northern blot analysis. Table S1 . (Continued).

245 views • 7 slides

Supplemental Table S1

58 views • 4 slides

More Related